The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Epilim Chrono 300mg Prolonged Release Tablets

300 milligram(s) Prolonged-release tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/150/011

Main Information

Trade NameEpilim Chrono 300mg Prolonged Release Tablets
Active SubstancesSodium valproate
Strength300 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/150/011

Group Information

ATC CodeN03AG Fatty acid derivatives
N03AG01 valproic acid


Licence Issued24/08/1992
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back